Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more.

Choose a location

    Kollicream® – Pharmaceutical-grade emollients with exceptional sensory qualities

    BASF’s Kollicream® emollients deliver exceptional performance for a wide variety of applications. 

    Primarily known for their skin softening and smoothing properties, emollients can also be used to adjust the consistency and appearance of creams and lotions. Our portfolio include excipients that feel like cosmetics on the skin, milder formulations for minimal irritation, and easy-to-apply products for large areas. Plus, the Kollicream® range offers unparalleled flexibility – allowing you to adapt variables such as spreading value, molecular weight, or water permeability in line with your needs.

    Enhance the sensory quality of your formulation
    Incredible flexibility – adapt variables in line with your needs
    Excipients with a cosmetic look and feel, milder formulations
    High-performance emollients for efficient topical drug delivery

    Product Overview

    Focusing on your needs with platform solutions

    This brochure also includes BASF's portfolio of emollients. It presents an overview of our leading-edge products, grouped in the following platforms: Skin Delivery, Instant & Modified Release, Solubilization, and Softgels.

    Technical Information

    Kollicream® Grades - Technical Information

    Emollients for topical application


    Pharmaceutical-grade ingredients for the dermatology industry - Because caring for skin needs the expert’s touch.

    BASF’s dermatology portfolio: the perfect solution for every challenge.


    The Effect of Emollient Selection on the Microstructure and Release of Clotrimazole from Topical Cream Formulations

    The objective of this study was to explore whether the selection of excipients (Q1) used in a topical semi-solid cream formulation, can impact the microstructural features of the formulation (Q3) and thereby key performance attributes (e.g. dermal drug delivery).


    Mildness of Dermal Excipients as Determined by In Vivo Clinical Patch Tests

    The objective of these studies was to determine the allergy and irritation potential of oleochemical-based excipients that BASF markets for pharmaceutical dermal applications (e.g. creams, ointments, gels, foams, etc.), by clinical patch testing on patients who are being screened for allergies due to chronic episodes of dermatitis.